Crizotinib
In Stock•Starting at $7 for 5 mg•Purity ≥ 98%
| CAS No. | 877399-52-5 |
|---|---|
| MDL No. | MFCD12407409 |
| MF | C21H22Cl2FN5O |
| MW | 450.30 |
| InChI Key | KTEIFNKAUNYNJU-GFCCVEGCSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 5 mg | 98% | $7 | In Stock | |
| 10 mg | 98% | $8 | In Stock | |
| 50 mg | 98% | $8 | In Stock | |
| 100 mg | 99% | $9 | In Stock | |
| 250 mg | 99% | $13 | In Stock |
Product Information
Crizotinib is a 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine with R configuration at the chiral center. It is the active enantiomer and functions as a kinase inhibitor, used in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). It serves as an antineoplastic agent, biomarker, and inhibitor of EC 2.7.10.1 (receptor protein-tyrosine kinase). It is an enantiomer of ent-crizotinib.
| CAS No. | 877399-52-5 |
|---|---|
| Product Name | Crizotinib |
Biological Targets
ALK·EML4·MET·MST1R·NPM1·
Associated Conditions
diffuse intrinsic pontine glioma·squamous cell carcinoma·Uveal Melanoma·neoplasm·bile duct carcinoma·
* The information provided here is compiled from public sources and is for reference only.
